Related Experiment Videos
X-linked myotubular and centronuclear myopathies
Christopher R Pierson1, Kinga Tomczak, Pankaj Agrawal
1Department of Pathology, Children's Hospital Boston, Massachusetts 02115, USA. cpierson@enders.tch.harvard.edu
Journal of Neuropathology and Experimental Neurology
|July 27, 2005
Summary
Centronuclear myopathies, including X-linked myotubular myopathy (XLMTM), involve muscle fiber abnormalities. Research is advancing understanding of their genetics and pathogenesis.
Area of Science:
- Neurology
- Genetics
- Muscle Diseases
Background:
- Centronuclear myopathies (CNMs) are a group of inherited muscle disorders characterized by hypotrophic myofibers with central nuclei.
- Morphological similarities exist with other neuromuscular conditions, leading to historical diagnostic challenges.
- Distinct inheritance patterns and clinical presentations differentiate various forms of CNM.
Purpose of the Study:
- To review the historical understanding and current knowledge of centronuclear myopathies.
- To provide an update on the histopathologic features, genetics, and pathogenesis of CNMs.
- To highlight the distinct characteristics of X-linked myotubular myopathy (XLMTM) and autosomal forms (AR CNM, AD CNM).
Main Methods:
- Review of existing literature on centronuclear myopathies.
- Analysis of histopathologic findings, genetic data, and clinical features.
- Comparison of different CNM subtypes, including XLMTM, AR CNM, and AD CNM.
Main Results:
- X-linked myotubular myopathy (XLMTM) is a severe form caused by mutations in the MTM1 gene, encoding myotubularin.
- Autosomal recessive CNM (AR CNM) presents with varied onset and clinical features, with subgroups identified.
- Autosomal dominant CNM (AD CNM) is typically milder and slowly progressive, often presenting in adulthood.
Conclusions:
- Significant advancements have been made in understanding the genetics and pathogenesis of CNMs.
- The genetic basis for autosomal forms of CNM remains largely unknown.
- Further research is crucial for characterizing and potentially treating these complex muscle disorders.